Company / Current Liabilities per Share
Vanda Pharmaceuticals Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.49
FY2025
5-year range
$1.36 / $2.49
FY2021-FY2025
Trend
+43.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.13 in FY2019 to $2.49 in FY2025.
Based on SEC 10-K filings.
2.49 in FY2025 with a 5-year CAGR of +15.1%.
Increased from $1.54 to $2.49 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +15.0%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 43.3% year-over-year.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.49 | +43.3% |
| FY2024 | $1.74 | +12.5% |
| FY2023 | $1.54 | -5.6% |
| FY2022 | $1.64 | +20.6% |
| FY2021 | $1.36 | +10.2% |
| FY2020 | $1.23 | +8.6% |
| FY2019 | $1.13 | -3.9% |
| FY2018 | $1.18 | -26.2% |
| FY2017 | $1.60 | +36.1% |
| FY2016 | $1.18 | -5.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026